- Report
- October 2024
- 200 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- May 2024
- 200 Pages
Global
From €3838EUR$4,150USD£3,203GBP
- Report
- May 2024
- 200 Pages
Global
From €3838EUR$4,150USD£3,203GBP
- Report
- May 2024
- 200 Pages
Global
From €3838EUR$4,150USD£3,203GBP
- Report
- October 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,431GBP
- Report
- August 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,431GBP
- Report
- July 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,431GBP
- Report
- August 2025
- 191 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 187 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 197 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 195 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 198 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 186 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 185 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- August 2025
- 181 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2775EUR$3,000USD£2,316GBP
- Report
- May 2025
- 114 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- May 2025
- 120 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- November 2025
- 200 Pages
Global
From €7353EUR$7,950USD£6,137GBP
- Report
- September 2023
- 115 Pages
Global
From €4162EUR$4,500USD£3,473GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more